Geneva, Switzerland, February 22, 2012 – The European Tech Tour today announced the 2012 Medtech Summit will be held October 16-17 in Lausanne, Switzerland. The Summit works by pairing up and coming European and Israeli start-ups and growth Medtech companies at different stages ranging from Seed to Pre-IPO, with industry players as well as leading cross-border venture capital and global investment firms. As these investment professionals represent more than €10 billion in investment capital, the event can provide great funding and partnership opportunities for participating Medtech companies.
Companies from the Medtech industry segment based in Europe can register to be selected to become one of 25 finalists. The application deadline is June 14, 2012.
Eric Le Royer will be the President of ETT 2012 Medtech Summit. Mr.Le Royer will be joined by venture capitalist Thom Rasche, Partner at Earlybird, who will act as Vice President of the Selection Committee and Tim Dyer, Co-Founder of Addex as Vice President of Sponsorship.
Eric Le Royer commented “The Medtech Summit 2012 will be a fantastic opportunity to showcase the best in emerging Medtech companies from across Europe. Europe is uniquely positioned in the medtech environment as THE place for clinical and technical innovation. Europe’s aging population provides ample market opportunities for start-ups to bring effective and cost efficient solutions to treat patients and minimize health care costs. “
This theme will be “Bridge to Asia”. Ching Zhu Chinese venture capitalist, Partner at Frontline Bioventures will support the theme to enable European venture capitalists and entrepreneurs to meet Asian MedTech leaders.
Eric Le Royer added: “Beyond efficient operational models and access to high growth markets, Asia is now well positioned to offer critical capabilities in terms of quality product development, clinical trials, financing and exit opportunities.”
Registration
Applicants can register for the Tour at http://www.techtour.com/Registration.htm
As part of the process applicants must submit a company profile, business plan and draft presentation together with the registration form.
Selection criteria
Applicants will be assessed on the uniqueness of their technology, the strength of their business model, vision, capability to execute on the business plan and the quality and track record of their management. Submissions will be reviewed by the selection committee, which is comprised of 20 senior business leaders from various backgrounds including venture capital, technology, research and economic promotion.
Rewards for finalists
The selected 25 finalists will have twenty minutes to present their business plans to high level investors from the global venture capital and technology industry, service providers and academics. In addition, they will benefit from networking opportunities, local and international media exposure and potential opportunities to secure funding.
About the European Tech Tour
The European Tech Tour Association (ETT) was founded in Geneva in 1998 in response to the growing interest in emerging technology companies in various European regions. ETT is an independent, not-for-profit organisation composed of key contributors to the high technology industry. The Association recognises that continued prosperity in Europe lies in its ability to transform today’s innovative projects into tomorrow’s global technology leaders. For further information, please visit www.techtour.com
